Free Trial

BioAtla (BCAB) Earnings Date, Estimates & Call Transcripts

BioAtla logo
$1.92
-0.10 (-4.95%)
(As of 05:32 PM ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 5Estimated
Actual EPS
(Aug. 8)
-$0.44 Beat By $0.01
Consensus EPS
(Aug. 8)
-$0.45
Skip Charts & View Estimated and Actual Earnings Data

BCAB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BCAB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioAtla Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.74)($0.74)($0.74)
Q2 20241($0.51)($0.51)($0.51)
Q3 20241($0.48)($0.48)($0.48)
Q4 20241($0.34)($0.34)($0.34)
FY 20244($2.07)($2.07)($2.07)

BCAB Earnings Date and Information

BioAtla last announced its quarterly earnings results on August 8th, 2024. The reported ($0.44) earnings per share for the quarter, beating analysts' consensus estimates of ($0.45) by $0.01. BioAtla has generated ($2.18) earnings per share over the last year (($2.18) diluted earnings per share). Earnings for BioAtla are expected to decrease in the coming year, from ($1.52) to ($1.74) per share. BioAtla has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off prior year's report dates.

BioAtla Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/5/2024
(Estimated)
------- 
8/8/2024Q2 2024($0.45)($0.44)+$0.01($0.44)--      
5/14/2024Q1 2024($0.57)($0.48)+$0.09($0.48)--  
3/26/2024Q4 2023($0.68)($0.56)+$0.12($0.56)--  
11/7/2023Q3 2023($0.77)($0.70)+$0.07($0.70)--  
8/1/2023Q2 2023($0.62)($0.75)($0.13)($0.75)--  
5/11/2023Q1 2023($0.66)($0.58)+$0.08($0.58)--
3/23/2023Q4 2022($0.74)($0.63)+$0.11($0.63)--  
11/4/2022Q3 2022($0.77)($0.69)+$0.08($0.69)--
8/9/2022Q2 2022($0.70)($0.77)($0.07)($0.77)--    
5/5/2022Q1 2022($0.69)($0.65)+$0.04($0.65)--
3/1/2022Q4 2021($0.72)($0.63)+$0.09($0.63)--
11/15/2021Q3($0.6440)($0.68)($0.0360)($0.68)--
8/12/2021Q2 2021($0.56)($0.90)($0.34)($0.90)-$0.25 million
5/11/2021Q1($0.5230)($0.56)($0.0370)($0.56)--
3/24/2021Q4($0.7790)($1.50)($0.7210)---

BioAtla Earnings - Frequently Asked Questions

When is BioAtla's earnings date?

BioAtla has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates. Learn more on BCAB's earnings history.

Did BioAtla beat their earnings estimates last quarter?

In the previous quarter, BioAtla (NASDAQ:BCAB) reported ($0.44) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.01. Learn more on analysts' earnings estimate vs. BCAB's actual earnings.

How can I listen to BioAtla's earnings conference call?

The conference call for BioAtla's latest earnings report can be listened to online. Listen to Conference Call

How can I read BioAtla's conference call transcript?

The conference call transcript for BioAtla's latest earnings report can be read online. Read Transcript

How much revenue does BioAtla generate each year?

BioAtla (NASDAQ:BCAB) has a recorded annual revenue of $250,000.00.

How much profit does BioAtla generate each year?

BioAtla (NASDAQ:BCAB) has a recorded net income of -$123.46 million. BCAB has generated -$2.18 earnings per share over the last four quarters.

What is BioAtla's EPS forecast for next year?

BioAtla's earnings are expected to decrease from ($1.52) per share to ($1.74) per share in the next year.


`

More Earnings Resources from MarketBeat


This page (NASDAQ:BCAB) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners